SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott H. Davis who wrote (1000)3/30/1999 3:38:00 PM
From: N  Read Replies (2) of 1972
 
Scott, could you please comment on this article in the 3/27/99 Economist, if you are so inclined:

"...According to Glenn Crocker, a consultant with Ernst and Young and author of a recent report on American biotechnology, ...almost half of the country's 327 public biotech firms have less than two years worth of cash left in their coffers....

...The serious institutional money, which tends to stay put a little longer, is no longer directed towards small cap biotechnology (later article says switched to internet stocks) firms...."

Thanks,
Nancy

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News